This site is intended for healthcare professionals
  • Home
  • /
  • News
  • /
  • New Spinraza data reinforce sustained efficacy and...
News

New Spinraza data reinforce sustained efficacy and longer term safety across a broad range of Spinal Muscular Atrophy patients . Biogen Inc.

Read time: 1 mins
Last updated:20th May 2020
Published:19th May 2020
Condition: Spinal Muscular Atrophy
Type: drug
Register now for full access to medthority.com